Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Eupraxia Pharmaceuticals Inc (EPRX.TO)

Eupraxia Pharmaceuticals Inc (EPRX.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Eupraxia Pharmaceuticals Inc 201-2067 Cadboro Bay Road Victoria BC V8R 5G4 CAN

https://www.eupraxiapharma.com P: 250-590-3968

Description:

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with significant unmet medical needs.

Key Statistics

Overview:

Market Capitalization, $K 142,490
Shares Outstanding, K 35,623
Annual Sales, $ 0 K
Annual Net Income, $ -28,221 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -6,043 K
60-Month Beta 1.17
% of Institutional Shareholders 0.18%

Growth:

1-Year Return -41.52%
3-Year Return -3.61%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%

Per-Share Information:

Latest Earnings Date N/A
Earnings Per Share ttm -1.20
EPS Growth vs. Prev Year -20.51%
Dividend Payout Ratio 0.00%

EPRX.TO Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -155.38%
Return-on-Assets % -82.89%
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales N/A
Price/Book 7.29
Book Value/Share 0.55
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar